| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 09/03/2026 |
3. Issuer Name and Ticker or Trading Symbol
ARCH CAPITAL GROUP LTD. [ ACGL ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Shares, $.0011 par value per share | 304,627 | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Stock Option (Right to Buy) | (1) | 05/08/2027 | Common Shares, $.0011 par value per share | 12,870 | $27.0867 | D | |
| Stock Option (Right to Buy) | (2) | 12/28/2027 | Common Shares, $.0011 par value per share | 13,746 | $25.2833 | D | |
| Stock Option (Right to Buy) | (3) | 05/11/2028 | Common Shares, $.0011 par value per share | 15,822 | $21.55 | D | |
| Stock Option (Right to Buy) | (4) | 02/28/2029 | Common Shares, $.0011 par value per share | 15,929 | $27.67 | D | |
| Stock Option (Right to Buy) | (5) | 02/27/2030 | Common Shares, $.0011 par value per share | 15,461 | $37.42 | D | |
| Stock Option (Right to Buy) | (6) | 02/26/2031 | Common Shares, $.0011 par value per share | 13,692 | $30.82 | D | |
| Stock Option (Right to Buy) | (7) | 02/25/2032 | Common Shares, $.0011 par value per share | 10,510 | $42.54 | D | |
| Stock Option (Right to Buy) | (8) | 02/24/2033 | Common Shares, $.0011 par value per share | 6,604 | $64.17 | D | |
| Stock Option (Right to Buy) | (9) | 03/06/2033 | Common Shares, $.0011 par value per share | 813 | $66.7 | D | |
| Stock Option (Right to Buy) | (10) | 02/27/2034 | Common Shares, $.0011 par value per share | 5,534 | $82.22 | D | |
| Stock Option (Right to Buy) | (11) | 03/04/2035 | Common Shares, $.0011 par value per share | 8,319 | $91.87 | D | |
| Stock Option (Right to Buy) | 05/02/2028 | 05/02/2035 | Common Shares, $.0011 par value per share | 7,682 | $92.48 | D | |
| Stock Option (Right to Buy) | (12) | 03/03/2036 | Common Shares, $.0011 par value per share | 8,721 | $100.48 | D | |
| Explanation of Responses: |
| 1. This stock option is exercisable in three equal annual installments commencing May 8, 2018, and the next two installments on May 8, 2019 and May 8, 2020, subject to the applicable award agreement. |
| 2. This stock option is exercisable in three equal annual installments commencing December 28, 2018, and the next two installments on December 28, 2019 and December 28, 2020, subject to the applicable award agreement. |
| 3. This stock option is exercisable in three equal annual installments commencing May 11, 2019, and the next two installments on May 11, 2020 and May 11, 2021, subject to the applicable award agreement. |
| 4. This stock option is exercisable in three equal annual installments commencing February 28, 2020, and the next two installments on February 28, 2021 and February 28, 2022, subject to the applicable award agreement. |
| 5. This stock option is exercisable in three equal annual installments commencing February 27, 2021, and the next two installments on February 27, 2022 and February 27, 2023, subject to the applicable award agreement. |
| 6. This stock option is exercisable in three equal annual installments commencing February 26, 2022, and the next two installments on February 26, 2023 and February 26, 2024, subject to the applicable award agreement. |
| 7. This stock option is exercisable in three equal annual installments commencing February 25, 2023, and the next two installments on February 25, 2024 and February 25, 2025, subject to the applicable award agreement. |
| 8. This stock option is exercisable in three equal annual installments commencing February 24, 2024, and the next two installments on February 24, 2025 and February 24, 2026, subject to the applicable award agreement. |
| 9. This stock option is exercisable in three equal annual installments commencing March 6, 2024, and the next two installments on March 6, 2025 and March 6, 2026, subject to the applicable award agreement |
| 10. The stock option is exercisable in three equal annual installments commencing February 27, 2025, and the next two installments on February 27, 2026 and February 27, 2027, subject to the applicable award agreement |
| 11. The stock option is exercisable in three equal annual installments commencing March 4, 2026, and the next two installments on March 4, 2027 and March 4, 2028, subject to the applicable award agreement. |
| 12. This stock option is exercisable in three equal annual installments commencing March 3, 2027, and the next two installments on March 3, 2028 and March 3, 2029, subject to the applicable award agreement. |
| Remarks: |
| /s/ Jerome Halgan | 09/14/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||